Avoid bupropion if you have a seizure disorder, a current or past eating disorder like bulimia or anorexia nervosa, abrupt alcohol or benzodiazepine withdrawal, or recent MAOI use
Early clinical studies of Retatrutide have reported impressive weight-loss outcomes, making it one of the most closely watched medications in obesity medicine
The most frequently reported digestive complaints include nausea (affecting approximately 15-44% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation
Days one and two (injection day and the day after) This is the highest impact window
Preclinical rodent models of postoperative ileus have been used to examine ghrelin-mimetic signaling on gastrointestinal motility (gastric emptying, intestinal transit)